Welcome to the e-CCO Library!

N799: Inflammatory bowel disease affects sexual female desire and sexual female excitement
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Barros J., Baima J., Renosto F., Silva R., Farineli E., Batista G., Dorna M., Saad-Hossne R., Sassaki L.

Created: Wednesday, 20 February 2019, 10:36 AM
N800: Statistical comparison of predictors of quality of life in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rivera Sequeiros A.*1, Gil García E.2, Chillόn Martinez R.3

Created: Wednesday, 20 February 2019, 10:36 AM
N801: Patient opinion assessment of a comprehensive clinical tool to improve health-care in inflammatory bowel disease. The Implica-2 project
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sanroman Alvarez L., Figueira Alvarez M., De Castro Parga M.L., Hernandez Ramirez V., Pineda Mariño J.R., Pereira Bueno S., Martinez Cadilla J., Romero Mosquera B.

Created: Wednesday, 20 February 2019, 10:36 AM
N802: Improving care for patients with perianal Crohn's disease; review of a perianal virtual clinic
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Yarrow H., Irving P., Williams A., Hibberts F., Koumoutsos I., Darakhshan A., Westcott E., Duncan J.

Created: Wednesday, 20 February 2019, 10:36 AM
N803: Accelerated infusions of biosimilar infliximab are safe and well tolerated and monitoring post-infusion is not required
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Robinson K., Wright A., Marshall L., Lobo A.

Created: Wednesday, 20 February 2019, 10:36 AM
N804: An evaluation of patient satisfaction with IBDoc calprotectin home test system
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Fitzgerald D.*1, Sugrue K.2, McCarthy J.2, Buckley M.2

Created: Wednesday, 20 February 2019, 10:36 AM
N805: Do we need to monitor patients after vedolizumab infusion?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Robinson K., Marshall L., Wright A., Lobo A.

Created: Wednesday, 20 February 2019, 10:36 AM
N806: Comparison of patient satisfaction between regular care and clinical trial care for IBD patients treated with biologicals
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Stolte S.*1, Aelvoet A.1, Van der Geugten J.2, Löwenberg M.1, D'Haens G.1

Created: Wednesday, 20 February 2019, 10:36 AM
N807: The use of a pre-screening tool for anti-TNFs in IBD in four North West NHS trusts: a study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Campbell R.*1, Gaskell S.2, Nelson E.3, Bloor R.3, Hocking J.4, Hickey T.4, Geraghty V.5, Hodgins J.5

Created: Wednesday, 20 February 2019, 10:36 AM
N808: Cooking workshops as strategy of health promotion of patients with inflammatory bowel diseases
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zaltman C.*1, Tavares L.2, De Cnop M.2, Grandin C.2

Created: Wednesday, 20 February 2019, 10:36 AM
N809: IBD control questionnaire: validation and evaluation as part of a virtual biologic clinic in Galway University Hospital, Ireland
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Keogh A., Burke M.

Created: Wednesday, 20 February 2019, 10:36 AM
N810: Audit of patient satisfaction with telephone reviews for inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Johns K.

Created: Wednesday, 20 February 2019, 10:36 AM
N811: Infliximab versus adalimumab: clinical and endoscopy response in ulcerative colitis patients. A prospective study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Silva R.P.L., Bissoli G.C., Farinelli E., Sibia C.F., Barros J.R., Renosto F.L., Hossne R.S., Baima J.P., Sassaki L.Y.

Created: Wednesday, 20 February 2019, 10:36 AM
N812: Re-designing the IBD nurse service for children and families in Glasgow using digital working – a tertiary centre experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Garrick V., Curtis L., Richmond L.

Created: Wednesday, 20 February 2019, 10:36 AM
N813: Reaction rates in patients transferred from biologic to bio-similar treatment for IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lloyd-Ford G., Gordon M., Lewis A.

Created: Wednesday, 20 February 2019, 10:36 AM
N814: Improvement in the treatment and management of patients affected by inflammatory bowel disease: hepatitis B and vaccination status
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Onidi F.M., Mocci G., Cabras F.

Created: Wednesday, 20 February 2019, 10:36 AM
N815: IBD Team Climate Inventory: finding solutions to team challenges
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Burke M., Keogh A.

Created: Wednesday, 20 February 2019, 10:36 AM
N816: Anti-TNF therapy improves the quality of life in patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Silva R.P.L., Baima J.P., Bissoli G.C., Farinelli E., Sibia C.F., Barros J.R., Biondi R.B., Renosto F.L., Hossne R.S., Sassaki L.Y.

Created: Wednesday, 20 February 2019, 10:36 AM
N817: Epidemiological profile of Crohn's disease and ulcerative colitis in a Brazilian single centre
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Farinelli E., Pagnin A.F., Silva R.P.L., Sibia C.F., Renosto F.L., Barros J.R., Baima J.P., Hossne R.S., Sassaki L.Y.

Created: Wednesday, 20 February 2019, 10:36 AM
N818: A specialized IBD unit infusion center is preferred by patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Koslowsky B., Mazuz B., Goldin E., Bar-Gil Shitrit A.

Created: Wednesday, 20 February 2019, 10:36 AM